1 / 14

Microbicides Advocacy at the EU level

Microbicides Advocacy at the EU level. Rebekah Webb European Coordinator, GCM. AIDS Fondet/ HIV Denmark. Interact Worldwide, NAT, THT, IHAA, ICW. Cairde. AIDS Fonds/SAN!. SENSOA; Stop AIDS Alliance; IPPF-EN. AIDES. Abraco. Grupo de Trabajo sobre del tratamiento del VIH; Creacion Positiva.

raisie
Download Presentation

Microbicides Advocacy at the EU level

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Microbicides Advocacy at the EU level Rebekah Webb European Coordinator, GCM

  2. AIDS Fondet/ HIV Denmark Interact Worldwide, NAT, THT, IHAA, ICW Cairde AIDS Fonds/SAN! SENSOA; Stop AIDS Alliance; IPPF-EN AIDES Abraco Grupo de Trabajo sobre del tratamiento del VIH; Creacion Positiva Global Campaign Europe HIV Norge

  3. EU Advocacy Goals • European Union is politically and financially supportive of microbicides • EU funding is effective and efficient • EU policy on development, research and health is pro-microbicide • EU regulatory policy is not a barrier to microbicide licensing and access • EU policy on microbicides recognises and supports the importance of community involvement in the microbicide effort • EU = 25 member states plus the Commission • Commission initiates policy, co-decision with Parliament

  4. Every European nation should be: • Funding microbicide R&D, including rectal and HIV positive research questions • Developing policies for introduction and use • Engaged in a dialogue with stakeholders on introduction • Building developing country health infrastructure supportive of trials • Contributing to EU mechanisms and policies for research • Encouraging the private sector to engage

  5. EU Member States Donors = NORWAYSWEDEN DENMARK N’LANDS IRELANDUK ‘Donors’ not yet converted: FINLAND GERMANYFRANCE BELGIUMSPAIN

  6. Increase in European public sector funding since 2000

  7. Resource tracking exercise • Total investment in 2004 was $140 million, of which only $3 million went to advocacy • Increase of more than 2 fold between 2000 and 2004 • Europe increased its share of funding from 2% to 23% • Largest funder is the NIH (US)

  8. What works? • Working in coalition • Regular info-sharing meetings in Bxls • Joint civil society statements • Timely interventions as part of civil society input into policy development • Letters to Ministers (Council) • Postcard campaigns • MEP champions in each committee and each party • Lobbying around specific issues

  9. Joint Statements

  10. From left to right: Poul Nyrup Rasmussen (PES President), Geena Gonsalves (Action Aid International), Michael Cashman (MEP), Ivy Kakiiza (Action Aid International), Marie-Arlette Carlotti (MEP), Marta Monteso Cullell (Stop AIDS Alliance), Tadeusz Iwinski (SLD Poland), Mamadou Diallo (IAVI) and Ruairi Quinn (LP Ireland)

  11. Write on the Minister’s speech!

  12. GCM Role: • The need for an independent entity to mobilise civil society participation in research • Enhance and monitor civil society participation in decision-making • Information sharing, networking and collaboration across regions, creation of common resources • Technical assistance to partners • Messaging and strategy development • Accountability – independence and engagement/coordination of civil society

More Related